IRIS UniCatt

Morganti, Alessio Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.917
NA - Nord America 6.995
AS - Asia 3.078
SA - Sud America 619
AF - Africa 107
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 15
Totale 18.750
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.827
DE - Germania 3.312
SE - Svezia 1.411
SG - Singapore 1.103
CN - Cina 1.081
UA - Ucraina 636
IT - Italia 624
BR - Brasile 567
FR - Francia 451
IE - Irlanda 336
GB - Regno Unito 323
IN - India 267
FI - Finlandia 216
ID - Indonesia 216
PL - Polonia 172
RU - Federazione Russa 137
CA - Canada 129
TR - Turchia 117
BE - Belgio 75
CI - Costa d'Avorio 67
CZ - Repubblica Ceca 56
JP - Giappone 45
NL - Olanda 43
HK - Hong Kong 42
VN - Vietnam 36
IR - Iran 32
KR - Corea 24
AT - Austria 22
MX - Messico 18
ES - Italia 13
LT - Lituania 13
ZA - Sudafrica 13
AU - Australia 12
BD - Bangladesh 12
EU - Europa 12
IQ - Iraq 12
AR - Argentina 11
EG - Egitto 11
RO - Romania 11
AZ - Azerbaigian 9
CH - Svizzera 9
CO - Colombia 9
PT - Portogallo 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
IL - Israele 8
MA - Marocco 8
SA - Arabia Saudita 8
EC - Ecuador 7
UZ - Uzbekistan 7
GR - Grecia 6
JO - Giordania 6
LK - Sri Lanka 6
PA - Panama 6
JM - Giamaica 5
KZ - Kazakistan 5
LA - Repubblica Popolare Democratica del Laos 5
LU - Lussemburgo 5
PE - Perù 5
PH - Filippine 5
RS - Serbia 5
VE - Venezuela 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
AM - Armenia 4
DK - Danimarca 4
HU - Ungheria 4
KE - Kenya 4
KG - Kirghizistan 4
NO - Norvegia 4
PK - Pakistan 4
BO - Bolivia 3
HR - Croazia 3
LV - Lettonia 3
MY - Malesia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
A1 - Anonimo 2
BG - Bulgaria 2
EE - Estonia 2
MK - Macedonia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AG - Antigua e Barbuda 1
BH - Bahrain 1
BS - Bahamas 1
BZ - Belize 1
CM - Camerun 1
DZ - Algeria 1
HN - Honduras 1
KY - Cayman, isole 1
MD - Moldavia 1
NI - Nicaragua 1
PR - Porto Rico 1
PY - Paraguay 1
SI - Slovenia 1
TM - Turkmenistan 1
Totale 18.748
Salva come PNG Salva come JPEG
Città #
Chandler 1.538
Singapore 655
Ashburn 516
Jacksonville 385
Dublin 334
San Mateo 310
Nanjing 230
Dearborn 216
Ann Arbor 215
Jakarta 213
Wilmington 192
Nürnberg 183
New York 155
Woodbridge 153
Warsaw 151
Boston 150
Milan 137
Bremen 127
The Dalles 123
Marseille 118
Beijing 105
Lawrence 103
Izmir 101
Los Angeles 96
Frankfurt am Main 94
Munich 94
Nanchang 92
Hyderabad 91
Cattolica 89
Princeton 85
Moscow 84
Houston 80
Helsinki 78
Fairfield 77
Brussels 75
Rome 72
Redwood City 71
Abidjan 67
Seattle 65
Leawood 61
Toronto 53
São Paulo 52
Zhengzhou 44
North York 42
Boardman 41
University Park 39
Hefei 38
Kunming 38
Shenyang 37
Düsseldorf 36
Hebei 36
Jiaxing 35
Augusta 34
Fremont 32
Changsha 29
Hong Kong 29
London 29
Tianjin 29
Phoenixville 28
Cambridge 27
Guangzhou 27
Lancaster 26
Mountain View 26
Norwalk 26
Detroit 25
Shanghai 24
Auburn Hills 23
Seoul 23
Hangzhou 22
Pune 22
Brno 21
Hanoi 20
Nuremberg 20
Lauterbourg 19
Washington 19
Bexley 18
Falls Church 18
Amsterdam 17
San Francisco 17
Turku 17
Wroclaw 17
Redmond 16
Roubaix 16
Monmouth Junction 15
Rio de Janeiro 14
Stockholm 14
Tokyo 14
Belo Horizonte 13
Chicago 13
Edinburgh 13
Lanzhou 13
Santa Clara 13
Enterprise 12
Ottawa 12
Andover 11
Brooklyn 11
Falkenstein 11
Jinan 11
Portsmouth 11
Bologna 10
Totale 9.199
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 811
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 263
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 260
A National project for in vivo dosimetry procedures in radiotherapy: First results 260
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 187
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 184
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 181
A National project for in vivo dosimetry procedures in radiotherapy: First results 178
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 176
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 162
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 159
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 157
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 156
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 152
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 151
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 151
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 150
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 149
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 148
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 148
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 144
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 144
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 143
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 143
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 143
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 143
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 139
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 139
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 137
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 137
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 136
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 136
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 134
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 134
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 133
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 132
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 130
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 126
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 126
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 126
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 125
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 124
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 124
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 124
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 124
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 124
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 123
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 122
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 122
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 122
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 121
In Vivo Portal Dosimetry by an Ionization Chamber 119
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 119
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 116
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 114
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 113
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 113
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 112
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 112
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 110
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 110
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 110
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 110
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 109
An in-vivo dosimetry procedure for Elekta step and shoot IMRT 108
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer 108
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 106
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 106
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 106
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 104
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 104
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 104
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 101
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 100
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 100
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 100
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 100
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 100
Real time transit dosimetry for the breath-hold radiotherapy technique experience 99
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 99
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 98
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 97
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 97
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 96
RANDOMIZED, MULTICENTER, PHASE IIB STUDY OF PREOPERATIVE CHEMORADIOTHERAPY IN T3 MID-DISTAL RECTAL CANCER: RALTITREXED + OXALIPLATIN + RADIOTHERAPY VERSUS CISPLATIN + 5-FLUOROURACIL + RADIOTHERAPY. 96
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 96
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 96
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 95
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 94
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 94
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 94
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 93
Underuse of brachytherapy for the treatment of dysphagia owing to esophageal cancer. An Italian survey 92
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 90
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 90
Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: Is there a place for critical swallowing structures dose sparing? 90
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 89
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 88
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 87
Preoperative chemoradiation with raltitrexed (Tomudex) in T2/N+ and T3/N+ rectal cancers: a phase I study. 84
Totale 13.231
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.951
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.951
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020163 0 0 0 0 0 0 0 0 0 0 0 163
2020/20211.452 81 171 30 156 204 64 140 42 167 107 228 62
2021/20221.822 188 130 32 108 116 69 28 257 73 125 332 364
2022/20234.181 569 590 312 678 273 475 230 342 464 37 160 51
2023/20241.806 66 532 83 149 44 231 103 137 18 49 235 159
2024/20253.796 107 98 253 141 430 95 83 186 658 435 812 498
Totale 19.436